Sequential Molecular Events in the Solid-State Acid-Base Incompatibility of Amlodipine Besylate and Citric Acid: 2D-COS-PXRD and 2D-COS-FTIR as Orthogonal Probes of Reaction Sequence in Drug-Excipient Solid-State Incompatibility.

Chenkual L, Lalchandani DS, Sathala PK, Divate M, Senapati A, Porwal PK

Open source

DOI
10.1021/acs.molpharmaceut.6c00390
Published
2026 Oct 5
Container
Molecular pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.6c00390,
  title = {Sequential Molecular Events in the Solid-State Acid-Base Incompatibility of Amlodipine Besylate and Citric Acid: 2D-COS-PXRD and 2D-COS-FTIR as Orthogonal Probes of Reaction Sequence in Drug-Excipient Solid-State Incompatibility.},
  author = {Chenkual L and Lalchandani DS and Sathala PK and Divate M and Senapati A and Porwal PK},
  year = {2026},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.6c00390},
  url = {https://doi.org/10.1021/acs.molpharmaceut.6c00390}
}

RIS

TY  - JOUR
TI  - Sequential Molecular Events in the Solid-State Acid-Base Incompatibility of Amlodipine Besylate and Citric Acid: 2D-COS-PXRD and 2D-COS-FTIR as Orthogonal Probes of Reaction Sequence in Drug-Excipient Solid-State Incompatibility.
AU  - Chenkual L
AU  - Lalchandani DS
AU  - Sathala PK
AU  - Divate M
AU  - Senapati A
AU  - Porwal PK
PY  - 2026
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.6c00390
UR  - https://doi.org/10.1021/acs.molpharmaceut.6c00390
ER  - 

APA

L, C., DS, L., PK, S., M, D., A, S., & PK, P. (2026). Sequential Molecular Events in the Solid-State Acid-Base Incompatibility of Amlodipine Besylate and Citric Acid: 2D-COS-PXRD and 2D-COS-FTIR as Orthogonal Probes of Reaction Sequence in Drug-Excipient Solid-State Incompatibility.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00390

Source records